Li, Jiangjin <br/><br/>
Cilostazol protects against myocardial ischemia and reperfusion injury by activating transcription factor EB (TFEB).  [electronic resource] 

 -  Biotechnology and applied biochemistry  Jul 2019 
 - 555-563 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1470-8744 
<br/><br/><label>Standard No.: </label>10.1002/bab.1754  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autophagy--drug effects<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--antagonists & inhibitors<br/>Cilostazol--pharmacology<br/>Disease Models, Animal<br/>Lysosomes--drug effects<br/>Myocardial Reperfusion Injury--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sirolimus--analogs & derivatives